Literature DB >> 7305429

Deficiency of non-suppressible insulin-like activity in thalassaemia major.

G A Werther, R Matthews, H G Burger, A C Herington.   

Abstract

The commonly occurring short stature in the condition of thalassaemia major was investigated with respect to the possible role of the somatomedin growth factor low molecular weight non-suppressible insulin-like activity (NSILAs). Nineteen affected patients (12 boys, 7 girls) aged between 2 and 21 years were studied. Twelve of them were on or below the 10th centile for height of whom 7 were on or below the 3rd centile for height. Serum immunoreactive growth hormone responses to exercise were normal in 9 of 11 subjects tested. Using an isolated fat cell bioassay NSILAs was undetectable in 10 and was more than 2 SD below the normal mean value in the other 9 subjects. High molecular weight NSILA (not a growth factor) was very low or undetectable in all 9 subjects tested. Low molecular weight NSILAs did not show the normal correlation with age in childhood, nor was there any correlation with height, height velocity, or bone age. The 2 children above the 50th centile for height had undetectable NSILAs. There was no evidence of iron or ferritin interfering in the bioassay, and mixing experiments showed no evidence of inhibitory activity towards NSILAs in thalassaemic sera. Low circulating levels of the somatomedin NSILAs may contribute to the short stature in thalassaemia major, but other factors may permit normal growth in some affected children.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305429      PMCID: PMC1627398          DOI: 10.1136/adc.56.11.855

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

Review 1.  Current concepts of somatomedin and other biologically related growth factors.

Authors:  R H Chochinov; W H Daughaday
Journal:  Diabetes       Date:  1976-10       Impact factor: 9.461

2.  Endocrinopathy in thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

Review 3.  Iron overload: clinical and pathologic aspects in pediatrics.

Authors:  R T O'Brien
Journal:  Semin Hematol       Date:  1977-01       Impact factor: 3.851

4.  Endocrine function in thalassemia major.

Authors:  V C Canale; P Steinherz; M New; M Erlandson
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

5.  Standards for children's height at ages 2-9 years allowing for heights of parents.

Authors:  J M Tanner; H Goldstein; R H Whitehouse
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

Review 6.  The regulation of growth by endocrines.

Authors:  W H Daughaday; A C Herington; L S Phillips
Journal:  Annu Rev Physiol       Date:  1975       Impact factor: 19.318

7.  Hormonal changes in thalassaemia major.

Authors:  D M Flynn; A Fairney; D Jackson; B E Clayton
Journal:  Arch Dis Child       Date:  1976-11       Impact factor: 3.791

8.  Endocrinological investigation of pituitary conadal axis in thalassemia major.

Authors:  C Anoussakis; D Alexiou; D Abatzis; G Bechrakis
Journal:  Acta Paediatr Scand       Date:  1977-01

9.  A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.

Authors:  R C Franklin; G C Rennie; H G Burger; D P Cameron
Journal:  J Clin Endocrinol Metab       Date:  1976-11       Impact factor: 5.958

10.  METHOD FOR THE AUTOMATIC DETERMINATION OF SERUM IRON.

Authors:  D S YOUNG; J M HICKS
Journal:  J Clin Pathol       Date:  1965-01       Impact factor: 3.411

View more
  2 in total

1.  Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis.

Authors:  R C Allen; M Jimenez; C T Cowell
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Circadian growth hormone secretion in short multitransfused prepubertal children with thalassaemia major.

Authors:  G Katzos; F Harsoulis; M Papadopoulou; M Athanasiou; K Sava
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.